299 related articles for article (PubMed ID: 15671555)
21. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
22. [Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma].
Wang DL; Wang YF; Shi GS; Huang H
Ai Zheng; 2007 Jun; 26(6):601-6. PubMed ID: 17562265
[TBL] [Abstract][Full Text] [Related]
23. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
Marko NF; Prayson RA; Barnett GH; Weil RJ
Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours.
Hara A; Saegusa M; Ichinoe M; Okayasu I
J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430
[TBL] [Abstract][Full Text] [Related]
26. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C
Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
[TBL] [Abstract][Full Text] [Related]
27. Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status.
Barresi V; Buttarelli FR; Vitarelli EE; Arcella A; Antonelli M; Giangaspero F
Hum Pathol; 2009 Dec; 40(12):1738-46. PubMed ID: 19716156
[TBL] [Abstract][Full Text] [Related]
28. Increased levels of p21WAF1/Cip1 in human brain tumors.
Jung JM; Bruner JM; Ruan S; Langford LA; Kyritsis AP; Kobayashi T; Levin VA; Zhang W
Oncogene; 1995 Nov; 11(10):2021-8. PubMed ID: 7478521
[TBL] [Abstract][Full Text] [Related]
29. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
[TBL] [Abstract][Full Text] [Related]
30. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
[TBL] [Abstract][Full Text] [Related]
31. Differences between phosphotyrosine accumulation and Neu/ErbB-2 receptor expression in astrocytic proliferative processes. Implications for glial oncogenesis.
Kristt DA; Yarden Y
Cancer; 1996 Sep; 78(6):1272-83. PubMed ID: 8826951
[TBL] [Abstract][Full Text] [Related]
32. Expression of transforming growth factor alpha in human gliomas.
Schlegel U; Moots PL; Rosenblum MK; Thaler HT; Furneaux HM
Oncogene; 1990 Dec; 5(12):1839-42. PubMed ID: 2284103
[TBL] [Abstract][Full Text] [Related]
33. Myelin basic protein (MBP) in human gliomas: a study of twenty-five cases.
Figols J; Iglesias-Rozas JR; Kazner E
Clin Neuropathol; 1985; 4(3):116-20. PubMed ID: 2410174
[TBL] [Abstract][Full Text] [Related]
34. Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target.
Barnett JA; Urbauer DL; Murray GI; Fuller GN; Heimberger AB
Clin Cancer Res; 2007 Jun; 13(12):3559-67. PubMed ID: 17575219
[TBL] [Abstract][Full Text] [Related]
35. Expression of tissue factor correlates with grade of malignancy in human glioma.
Hamada K; Kuratsu J; Saitoh Y; Takeshima H; Nishi T; Ushio Y
Cancer; 1996 May; 77(9):1877-83. PubMed ID: 8646688
[TBL] [Abstract][Full Text] [Related]
36. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma.
Bosher JM; Totty NF; Hsuan JJ; Williams T; Hurst HC
Oncogene; 1996 Oct; 13(8):1701-7. PubMed ID: 8895516
[TBL] [Abstract][Full Text] [Related]
37. Expression of the tumor suppressor gene DCC in human gliomas.
Scheck AC; Coons SW
Cancer Res; 1993 Dec; 53(23):5605-9. PubMed ID: 8242611
[TBL] [Abstract][Full Text] [Related]
38. Expression of diagnostic neuronal markers and outcome in glioblastoma.
Donev K; Scheithauer BW; Rodriguez FJ; Jenkins S
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):411-21. PubMed ID: 20298476
[TBL] [Abstract][Full Text] [Related]
39. Loss of DCC expression and glioma progression.
Reyes-Mugica M; Rieger-Christ K; Ohgaki H; Ekstrand BC; Helie M; Kleinman G; Yahanda A; Fearon ER; Kleihues P; Reale MA
Cancer Res; 1997 Feb; 57(3):382-6. PubMed ID: 9012460
[TBL] [Abstract][Full Text] [Related]
40. Expression of Fas/APO-1 during the progression of astrocytomas.
Tachibana O; Nakazawa H; Lampe J; Watanabe K; Kleihues P; Ohgaki H
Cancer Res; 1995 Dec; 55(23):5528-30. PubMed ID: 7585627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]